High IFN-α and IFN-β signaling was observed in patients with mild to moderate COVID-19 while low IFN-α and IFN-β was observed in patients with severe COVID-19 symptoms, suggesting that overcoming type I IFN blockade may lead to milder symptoms (Acharya et al., 2020). Here, IFNB1 is linked to COVID-19.